For professionals in the pharmaceutical and chemical industries, understanding the properties and applications of key intermediates is paramount. Revaprazan Hydrochloride, identified by CAS number 178307-42-1, stands out as a vital compound, particularly in the development of treatments for gastrointestinal (GI) disorders. As a leading pharmaceutical intermediate manufacturer based in China, we are dedicated to supplying high-purity Revaprazan HCl to support your research and production needs.

Revaprazan Hydrochloride is a novel, reversible proton pump inhibitor (PPI) that acts as a potassium-competitive acid pump antagonist. This unique mechanism allows it to effectively manage gastric acid secretion, offering a distinct advantage over traditional irreversible PPIs. Its primary applications lie in the treatment of conditions such as duodenal ulcers, gastric ulcers, and gastritis. The compound's ability to rapidly inhibit gastric acid secretion without causing the adverse effects of prolonged acid deficiency makes it a valuable therapeutic agent.

The chemical structure of Revaprazan Hydrochloride is complex, with the molecular formula C22H23FN4.HCl and a molecular weight of 398.90 g/mol. Its efficacy in clinical applications underscores the importance of sourcing this intermediate from a reputable supplier. We specialize in providing Revaprazan HCl with a purity of ≥99%, ensuring that your downstream synthesis processes benefit from a high-quality, consistent raw material. This high purity is critical for ensuring the safety and efficacy of the final pharmaceutical product.

When considering where to buy Revaprazan Hydrochloride, it is essential to partner with manufacturers who adhere to stringent quality control standards and possess a deep understanding of chemical synthesis. Our manufacturing processes are optimized to produce Revaprazan HCl efficiently, offering competitive pricing and a reliable supply chain for bulk orders. We aim to be your preferred supplier, facilitating your access to this crucial pharmaceutical intermediate.

For researchers and procurement managers, understanding the synthesis pathways and potential impurities of Revaprazan Hydrochloride is key to successful product development. We continuously invest in R&D to refine our production methods, ensuring that we meet the evolving demands of the pharmaceutical market. If your project requires Revaprazan HCl for API synthesis or for exploring its therapeutic potential, we encourage you to contact us for a quotation and sample. Partnering with a trusted manufacturer in China can significantly streamline your procurement process and ensure the quality of your research outcomes.